Breast Cancer Her2 Prognosis
In the U.S., over 90 percent of breast cancer diagnoses occur during early stages of breast cancer. Early detection is good news for the patient, as it often translates into effective treatment.
However, early diagnosis is only a fraction of the general medical imaging. Other disease characteristics, such as hormone receptors and lymph nodes, can help in prognosing results and help doctors and patients choose the treatment.
Although breast cancer is increasing in North America and the UK, the mortality rate is decreasing. This decrease mortality is attributed to a greater number of women obtaining mammograms, improved assessment techniques and effective treatments auxiliaries.
Thus, if the majority of diagnosed cases of breast cancer are discovered during the preliminary stages, what effect does that have on patients and what are the best course of treatment?
The early stages of breast cancer
The early stages of breast cancer called TNM stages 1, 2 and 3a. This system rating is close to what has been far advanced carcinoma. It is also according to whether tumors are present in operation.
Most cases of early-stage breast cancer are curable with surgery, radiotherapy or systemic therapy. The survival rate of patients diagnosed with early this 5-year success rate of over 75%.
Normal processing reactions
The general reaction, treatment depends on the commitment of lymph nodes, size and degree of any tumor, patient age, hormones (estrogen and progesterone) receptors, and the status or condition marker biological and HER2/neu.
Lymph Indicators
Lymph nodes are an effective way to predict the effects of lactation cancer. In essence, the more positive lymph nodes are present, the lowest rate of patient survival and the greater the potential for relapse.
Commonly, patients with earlier stage breast cancer are classified as either negative nodes present from 1 to 3 positive nodes, 4 to 9 lymph positive or 10 or more nodes.
Tumor size
If a patient presents with lymph node negative and a tumor that is less than 1 cm, the prognosis is very good. Most doctors use tumor size as an effective and critical indicator during the early stages of this disease.
The degree tumor
As the tumor grade increases, so does the potential relapse rate. However, due to the unreliability of the data of the tumor, most pathologists do not rely on this information for prognosis.
The estrogen and progesterone receptors
Estrogen and progesterone in the tumor is also used to predict breast cancer in early stages. In general, patients with receptor positive breast cancer tend to have a better prognosis and survival rate than those who do not.
HER2/neu as an indicator
HER2/neu is what is called a marker – is an biological normally present in the body or within the tumor in 25% of cases of breast cancer. HER2/neu When levels are high, which usually translates to a variety more aggressive breast cancer and a worse prognosis.
Patient Age
In general, patients who are older (50 and over) have a better prognosis patients under 35 years.
